Back to Aberdeen Group plc Aberdeen Group plc

COAGCOAG
1 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in HEMAB THERAPEUTICS HOLDI

Yes. Aberdeen Group holds 52,117 shares of COAG (Hemab Therapeutics Holdi), worth $1.9M, as of its Q2 2026 13F filing.

Current Value

$1.9M

Current Shares

52,117

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
52,117
-
$1.9M0.0%$36.73
36

Other major holders of COAG: RA CAPITAL MANAGEMENT, L.P., FMR LLC, Capital International Investors, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used